Clinical Trial Update: PRF+1% MF for Class II Mandibular Furcation Defects [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating PRF+1% MF for Class II mandibular furcation defects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• PRF+1% MF

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Furcation Defects | Phase 2, Phase 3 | Status: COMPLETED